NCT02805894 - NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions

Prostate Cancer

Interventions

DRUG

NBTXR3 activated by IMRT only

Single local administration of NBTXR3 by injection into the prostate gland prior to the IMRT treatment

DRUG

NBTXR3 activated by Brachytherapy & IMRT

Single local administration of NBTXR3 by injection into the prostate gland prior to the Brachytherapy \& IMRT treatment

Trial Locations (2)

Thomas Jefferson University Hospital, Philadelphia

Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston